Skip to main content
. 2017 Apr 11;12(4):e0175337. doi: 10.1371/journal.pone.0175337

Table 2. Comparison of immunological variables between patients with and without acute GVHD.

Immunological variables ^ Pre-SCT aGVHD onset*
a GVHD a GVHD
Yes No p Yes No p
CD4+(total) 268 (57–1215) 228 (4–1118) 0,59 100 (1–1174) 24 (0–405) 0,07
RTE 10 (3–123) 25 (0–94) 0,64 4 (0–115) 0 (0–24) 0,01
CD4+naïve 37 (4–316) 56 (1–205) 0,84 8 (0–165) 0 (0–34) 0,005
CD4+TCM 113 (37–1092) 98 (2–233) 0,30 25 (0–254) 8 (0–86) 0,03
CD4+TEM 63 (2–210) 59 (2–769) 0,90 45 (0–986) 16 (0–318) 0,26
CD4+TEMRA 2 (0–14) 2 (0–209) 0,66 2 (0–36) 0 (0–20) 0,02
Treg (total) 16 (3–429 17 (1–45) 0,97 7 (0–30) 2 (0–11) 0,005
Treg naïve 1 (0–19) 3 (0–12) 0,41 2 (0–6) 0 (0–5) 0,02
TregCM 8 (2–18) 5 (0–21) 0,29 3 (0–17) 0 (0–4) 0,006
TregEM 6 (0–25) 6 (1–22) 0,90 3 (0–17) 1 (0–7) 0,01
CD8+(total) 151 (10–870) 147 (1–998) 0,84 44 (1–1109) 30 (0–1138) 0,27
CD8+ naïve 17 (1–126) 16 (0–105) 0,80 4 (0–85) 2 (0–21) 0,25
CD8+TCM 11 (1–60) 9 (0–83) 0,95 3 (0–34) 1 (0–17) 0,08
CD8+TEM 63 (1–520) 29 (0–566) 0,30 26 (0–360) 21 (0–669) 0,50
CD8+TEMRA 44 (1–446) 65 (0–469) 0,82 8 (0–603) 5 (0–434) 0,37
CD19+(total) 22 (0–102) 32 (0–145) 0,50 1 (0–11) 0 (0–19) 0,27
Immature CD19+ 4 (0–38) 9 (0–95) 0,19 0 (0–7) 0 (0–6) 0,81
Mature CD19+ 10 (0–93) 16 (0–100) 0,88 1 (0–11) 0 (0–15) 0,40
CD19+ naïve 5 (0–50) 4 (0–93) 0,98 0 (0–9) 0 (0–11) 0,70
UM CD19+ 0 (0–12) 0 (0–4) 0,41 0 (0–1) 0 0,40
SM CD19+ 1 (0–24) 1 (0–7) 0,67 0 (0–2) 0 (0–1) 0,80
M/DN CD19+ 0 (0–7) 1 (0–5) 0,50 0 (0–1) 0 (0–1) 0,85
TRECs/ml 63 (0–1360) 57 (0–1960) 0,78 82 (0–1769) 23 (0–885) 0,34
KRECs/ml 5099 (0–23957) 9319 (0–79533) 0,04 191 (0–3914) 78 (0–9764) 0,59

SCT = stem cell transplantation; aGVHD = acute GVHD; RTE = recent thymic emigrants; CM = central memory; EM = effector memory; TEMRA = terminally differentiated effector memory; UM = unswitched memory; SM = switched memory; M/DN = memory double negative; TRECs = T-cell receptor excision circles; KRECs = k-deleting recombination excision circles

^ Lymphocyte counts are expressed as cells/μl (median; range). Significant differences in percentage of lymphocyte subsets are reported in the section “Results”.

*Values at day+28 were analysed for patients without aGVHD.